Literature DB >> 3538834

Sonography in the follow-up of 100 patients with thyroid carcinoma.

J F Simeone, G H Daniels, D A Hall, K McCarthy, D B Kopans, R J Butch, P R Mueller, D D Stark, J T Ferrucci, C A Wang.   

Abstract

High-frequency, high-resolution sonography was used to detect recurrent thyroid carcinoma in 73 patients with papillary carcinoma, 16 with medullary carcinoma, 10 with follicular carcinoma, and one with small-cell carcinoma. Of the 36 patients with negative sonograms, 35 had no other evidence of recurrence, while one had surgical proof of recurrence. Of 25 patients with positive sonograms, confirmed with surgery or radioactive iodine (I131) scanning (sonographic sensitivity 96%, specificity 83%), palpation was negative in 17 (palpation sensitivity 32%, specificity 100%). Thirty-two patient with positive sonographic findings had no objective clinical proof of recurrence. There were seven false-positive studies. This study suggests that sonography may be the method of choice for earliest detection and localization of recurrent carcinoma of the thyroid.

Entities:  

Mesh:

Year:  1987        PMID: 3538834     DOI: 10.2214/ajr.148.1.45

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer.

Authors:  Hussam M Binyousef; Ali S Alzahrani; Saif S Al-Sobhi; Suhaibani Hamed S Al; Mohammed A Chaudhari; Hussain M Raef
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

2.  Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer.

Authors:  A S Alzahrani; H Raef; A Sultan; S Al Sobhi; S Ingemansson; M Ahmed; A Al Mahfouz
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

3.  Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective.

Authors:  Stephanie Cham; Kyle Zanocco; Cord Sturgeon; Michael W Yeh; Avital Harari
Journal:  Thyroid       Date:  2014-03-21       Impact factor: 6.568

4.  Scintigraphic detection of recurrence of medullary thyroid cancer.

Authors:  M Koizumi; Y Yamada; E Nomura; M Amano; Y Okajima; H Okizuka; K Yamada; S Sawano; T Kitahara; T Yamashita
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

5.  Calcitonin stimulation tests for the early diagnosis and follow-up of patients with C cell disease: a descriptive analysis.

Authors:  I Vainas; A Marthopoulos; A Chrisoulidou; K Raptou; K Tziomalos; K Pazaitou-Panayiotou
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

6.  Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.

Authors:  Matthias Schott; Holger S Willenberg; Cornelia Sagert; Thi-Bang-Tam Nguyen; Sven Schinner; Mathias Cohnen; Kenko Cupisti; Claus F Eisenberger; Wolfram T Knoefel; Werner A Scherbaum
Journal:  Clin Endocrinol (Oxf)       Date:  2007-03       Impact factor: 3.478

7.  FPR1 is the plague receptor on host immune cells.

Authors:  Patrick Osei-Owusu; Thomas M Charlton; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nature       Date:  2019-09-18       Impact factor: 49.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.